C Diff Update: The Latest News and Research

News
Article

Here is a review of the most up-to-date information around the infection.

image of microscope

There has been some interesting news, research, and even federal legislation around this healthcare-associated infection. Read the latest on Clostridioides difficile (C diff) in the updates below.

Having an Infectious Disease Provider Follow C diff Patients Reduces Hospital Admission for Recurrence
A hospital CDI intervention program that supported patients via an ID specialist demonstrated clinical benefits compared to another hospital where patients were followed by providers of any specialty.

Making C diff a Nationally Notifiable Infectious Disease and Condition
A bill in the House of Representatives was just introduced with the advocacy of the Peggy Lillis Foundation in hopes of bringing more recognition and research to the healthcare-associated infection.

Are Probiotics Beneficial to Pediatric Population During Antibiotic Treatment?
A secondary analysis of a randomized trial points to limited benefits on the microbiota.

Investigational C Diff Therapy Shows Favorable Microbiome Characteristics, Phase 3 Trial Planned
In additional analyses, the novel antibiotic, ibezapolstat, demonstrated favorable gut microbiome changes including increased relative proportion of Actinobacteria in ibezapolstat-treated patients with C diff Infection (CDI).

Reducing Unnecessary C diff Tests Aids in Diagnostic Stewardship, Overtreatment

A Florida hospital takes a novel approach for the healthcare-associated infection and reduced inappropriate testing by setting up guidelines.

Newsletter

Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.